Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligo-metastatic Stage IV Non-small Cell Lung Cancer”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)Study completedNCT01282450
What this trial is testing

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage IV (Oligo-metastases)Non-small Cell Lung Cancer
Maastricht Radiation Oncology 60
Testing effectiveness (Phase 2)UnknownNCT04767009
What this trial is testing

SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors

Who this might be right for
NSCLC Stage IV
Fudan University 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Testing effectiveness (Phase 2)Ended earlyNCT04908956
What this trial is testing

Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)

Who this might be right for
NSCLC Stage IVEGFR Gene Mutation
ETOP IBCSG Partners Foundation 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT06219317
What this trial is testing

Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC

Who this might be right for
NSCLC Stage IV
European Organisation for Research and Treatment of Cancer - EORTC 136
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 104
Early research (Phase 1)Looking for participantsNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Not applicableUnknownNCT06207292
What this trial is testing

Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer

Who this might be right for
NSCLCNSCLC Stage IVOligometastatic Disease+9 more
Radiotherapy Oncology Centre "Santa Maria" Hospital 100
Large-scale testing (Phase 3)UnknownNCT02076477
What this trial is testing

The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）

Who this might be right for
Oligo-metastatic Stage IV Non-small Cell Lung Cancer
Sichuan Cancer Hospital and Research Institute 420
Testing effectiveness (Phase 2)Looking for participantsNCT05277844
What this trial is testing

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

Who this might be right for
Oligometastatic DiseaseNon-small Cell Lung CancerDriver Mutation
Tata Memorial Hospital 106
Not applicableUnknownNCT03916913
What this trial is testing

TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Chinese Academy of Medical Sciences 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT03965468
What this trial is testing

Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC

Who this might be right for
Non-small Cell Lung CancerStage IVOligometastasis
ETOP IBCSG Partners Foundation 96